Skip to main content
NRIX filings

Corporate insider profile

Gwenn Hansen Filing Activity

Latest reported as Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX).

Purchase filings
0
Reported companies
1
Net open-market value
-$161,377.99
Latest transaction
Jun 25, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 25, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale5,394$20.00$107,880
Apr 30, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale3,214$16.65$53,498